Stay updated on Nivolumab vs Dacarbazine in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Dacarbazine in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Dacarbazine in Melanoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added Melanoma and MedlinePlus Genetics as related topics on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-09T00:43:58.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page no longer lists the disease 'Melanoma' in the study content and removes the 'MedlinePlus Genetics' related topics link.
    Difference
    0.1%
    Check dated 2025-12-01T18:27:42.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Melanoma is added as a related topic and MedlinePlus Genetics references are included; a note about PubMed publications was updated to reflect a revision (Revision: v3.3.2) and the previous version reference (Revision: v3.2.0) was removed.
    Difference
    0.2%
    Check dated 2025-11-24T16:56:30.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the government funding status notice about NIH operations from the page; this change does not affect the study details, eligibility criteria, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T15:06:19.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Melanoma and the MedlinePlus Genetics related topics section were removed from the page.
    Difference
    0.1%
    Check dated 2025-11-10T05:42:14.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Added related topics: Melanoma and MedlinePlus Genetics to the page.
    Difference
    0.3%
    Check dated 2025-11-03T01:33:55.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Dacarbazine in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Dacarbazine in Melanoma Clinical Trial page.